BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15678388)

  • 41. Metabolic studies in a patient with idiopathic hypophosphatemic osteomalacia.
    Weiss M; Schechter P; Bab I; Mekhmandarov S; Bank H; Eisenstein Z
    Isr J Med Sci; 1988 Jan; 24(1):46-50. PubMed ID: 3346150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-induced osteomalacia: a case of diagnostic dilemma.
    Robertson A; Mansberg R; Mansberg V; Van der Wall H; Hooper M
    Clin Nucl Med; 2007 Aug; 32(8):631-4. PubMed ID: 17667438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth and bone mineral density in a child with X-linked hypophosphatemic rickets: early response to treatment.
    Sugiyama T; Tanaka H; Kawai S
    J Bone Miner Metab; 1999; 17(2):137-40. PubMed ID: 10340642
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypophosphatemic osteomalacia complicating von Recklinghausen's neurofibromatosis: increase in spinal density on treatment.
    Hogan DB; Anderson C; MacKenzie RA; Crilly RG
    Bone; 1986; 7(1):9-12. PubMed ID: 3083847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogenic osteomalacia from pterygopalatine fossa mass.
    Savage CR; Zimmer LA
    J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone scintigraphy in a case of oncogenous osteomalacia.
    Ohta H; Nakaishi S; Oki S; Simizu M; Watanabe H; Fujikawa S; Nakade M; Watanabe H; Kohno K; Shintaku M
    Clin Nucl Med; 1998 Jul; 23(7):467-9. PubMed ID: 9676956
    [No Abstract]   [Full Text] [Related]  

  • 47. Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature.
    McMurtry CT; Godschalk M; Malluche HH; Geng Z; Adler RA
    J Am Geriatr Soc; 1993 Sep; 41(9):983-5. PubMed ID: 8409185
    [No Abstract]   [Full Text] [Related]  

  • 48. Octreotide therapy for tumor-induced osteomalacia.
    Seufert J; Ebert K; Müller J; Eulert J; Hendrich C; Werner E; Schuüze N; Schulz G; Kenn W; Richtmann H; Palitzsch KD; Jakob F
    N Engl J Med; 2001 Dec; 345(26):1883-8. PubMed ID: 11756579
    [No Abstract]   [Full Text] [Related]  

  • 49. Localisation of mesenchymal tumours by somatostatin receptor imaging.
    Jan de Beur SM; Streeten EA; Civelek AC; McCarthy EF; Uribe L; Marx SJ; Onobrakpeya O; Raisz LG; Watts NB; Sharon M; Levine MA
    Lancet; 2002 Mar; 359(9308):761-3. PubMed ID: 11888589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
    Hesse E; Moessinger E; Rosenthal H; Laenger F; Brabant G; Petrich T; Gratz KF; Bastian L
    J Bone Miner Res; 2007 Jan; 22(1):158-62. PubMed ID: 17014386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral insufficiency fracture of the femoral head and neck in a case of oncogenic osteomalacia.
    Chouhan V; Agrawal K; Vinothkumar TK; Mathesul A
    J Bone Joint Surg Br; 2010 Jul; 92(7):1028-31. PubMed ID: 20595128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
    Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
    World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oncogenic osteomalacia -- hypophosphataemic spectrum from "benignancy" to "malignancy".
    Chiam P; Tan HC; Bee YM; Chandran M
    Bone; 2013 Mar; 53(1):182-7. PubMed ID: 23220596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypophosphatemic osteomalacia induced by intravenous iron therapy: a case report.
    Samões B; Silva B; Martins A; Oliveira D; Rajão Martins F; Fonseca D; Costa L; Bernardes M
    Joint Bone Spine; 2023 Sep; 90(5):105586. PubMed ID: 37127260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypophosphataemic osteomalacia in patients receiving haemodialysis.
    Mahony JF; Hayes JM; Ingham JP; Posen S
    Br Med J; 1976 Jul; 2(6028):142-4. PubMed ID: 1276833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Posttransplant bone disease: a case illustrating dramatic improvements in bone density with vitamin D replacement therapy.
    Dhingra RK; Sprague SM; Ojo AO; Leavey SF
    Transplantation; 2001 Jun; 71(12):1856-9. PubMed ID: 11455270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome.
    Kumar S; Diamond T
    Bone Rep; 2020 Jun; 12():100276. PubMed ID: 32455150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial adult onset X-linked hypophosphataemic osteomalacia (report of a family; clinical and experimental studies).
    Radó JP; Haris A; Szebenyi B
    Acta Physiol Hung; 1997-1998; 85(3):199-214. PubMed ID: 10101535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarkers and imaging in non-malignant and malignant osteomalacia.
    Lüftner D; Bollow M; Stürzenbecher A; Kaufmann ; Priem F; Richter A; Gunther S; Geppert R; Petrides PE; Wernecke KD; Possinger K
    Int J Biol Markers; 2001; 16(2):136-41. PubMed ID: 11471897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.